Previous studies suggest that PUMA can mediate the pro-apoptotic effect of the chemotherapy drug oxaliplatin in colon cancer and non-small cell lung cancer, serving as a biomarker to predict tumor sensitivity to pemetrexed [26]. Here, BBC3 is linked to neoplasm.